| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |